iSpecimen (ISPC) Share-based Compensation Growth (1y) (2021 - 2026)
iSpecimen (ISPC) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 500.00% |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 | -96.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.59% |
| Dec 31, 2025 | -83.91% |
| Sep 30, 2025 | -99.54% |
| Jun 30, 2025 | -100.19% |
| Mar 31, 2025 | 6.88% |
| Dec 31, 2024 | -89.85% |
| Sep 30, 2024 | -85.40% |
| Jun 30, 2024 | -81.20% |
| Mar 31, 2024 | -93.26% |
| Dec 31, 2023 | 139.53% |
| Sep 30, 2023 | -99.46% |
| Jun 30, 2023 | -99.33% |
| Mar 31, 2023 | 19.81% |
| Dec 31, 2022 | -73.73% |
| Sep 30, 2022 | 77,755.33% |
| Jun 30, 2022 | 234,148.19% |
| Mar 31, 2022 | 18,752.71% |
| Dec 31, 2021 | 1,300.66% |
| Sep 30, 2021 | 13.01% |
| Jun 30, 2021 | -59.44% |